Trials in rhesus macaques show that a subunit vaccine against SARS-CoV-2, comprising the spike protein receptor-binding domain displayed on a nanoparticle protein scaffold, produces a robust protective response against the virus.
- Prabhu S. Arunachalam
- Alexandra C. Walls
- Bali Pulendran
